Ocular toxicity from high-dose cytosine arabinoside
โ Scribed by Paul S. Ritch; Richard M. Hansen; Dale K. Heuer
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 321 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We report a severe parkinsonian condition following high dose, parenteral cytosine arabinoside (Cytosar) that persisted for 8 weeks. The drug was used in a patient with acute myelogenous leukemia that was refractory to all other treatment. The syndrome was partially responsive to antiparkinsonian dr
Eleven patients received allogeneic bone marrow from all HCA-identical sibling for the treatment of acute leukemia. The preparative regiment included high-dose cytosine arabinoside (Ara-C), 3 g/m2q 12 h for 12 doses, and lo00 rad singlefraction total body irradiation (5 patients) or 1200 rad fractio